Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). ETHK Labs's share price for the quarter that ended in Dec. 2025 was HK$2.64. ETHK Labs's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 1,602 Mil. Therefore, ETHK Labs's market cap for the quarter that ended in Dec. 2025 was HK$4,230 Mil.
ETHK Labs's quarterly market cap
increased
from Dec. 2024 (HK$2,921 Mil) to Jun. 2025 (HK$3,561 Mil) and
increased
from Jun. 2025 (HK$3,561 Mil) to Dec. 2025 (HK$4,230 Mil).
ETHK Labs's annual market cap
increased
from Dec. 2023 (HK$2,506 Mil) to Dec. 2024 (HK$2,921 Mil) and
increased
from Dec. 2024 (HK$2,921 Mil) to Dec. 2025 (HK$4,230 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. ETHK Labs's Enterprise Value for Today is HK$2,598 Mil.
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
ETHK Labs Market Cap Related Terms
ETHK Labs Market Cap Historical Data
* Premium members only.
The historical data trend for ETHK Labs's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:01931 vs MCK, COR, CAH: Market Cap Comparison
For the Medical Distribution subindustry, ETHK Labs's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ETHK Labs Market Cap vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, ETHK Labs's Market Cap distribution charts can be found below:
* The bar in red indicates where ETHK Labs's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
ETHK Labs's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ETHK Labs (HKSE:01931) has a Market Cap of HK$929 Mil as of Aug. 05, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on ETHK Labs and its competitors. According to the industry distribution chart, ETHK Labs ranks #67 out of 121 companies in the Medical Distribution industry, placing it in the top 55.4%.
Is ETHK Labs' Market Cap too high?
ETHK Labs' current Market Cap is HK$929 Mil. Based on the distribution chart, ETHK Labs ranks #67 out of 121 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, ETHK Labs has a GF Score™ of 74/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does ETHK Labs' Market Cap compare to MCK and COR?
According to the Medical Distribution industry distribution chart, ETHK Labs ranks #67 out of 121 companies for Market Cap. This places ETHK Labs in the lower half of its industry. The industry median Market Cap is 142.18. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Distribution company?
The median Market Cap among Medical Distribution companies is 142.18, based on 121 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on ETHK Labs and its competitors. For the Medical Distribution industry, the median Market Cap is 142.18 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ETHK Labs's current Market Cap is HK$929 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ETHK Labs stock overvalued right now?
Based on GuruFocus' analysis, ETHK Labs (HKSE:01931) is currently considered Possible Value Trap. The stock's GF Value™ is HK$1.38, compared to a current price of HK$0.58 — trading 58% below its estimated fair value. The current Market Cap is HK$929 Mil. ETHK Labs' overall GF Score™ is 74/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For ETHK Labs (HKSE:01931), the current Market Cap is HK$929 Mil as of Aug. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ETHK Labs (HKSE:01931) Overvalued in 2026?
Based on GuruFocus' analysis, ETHK Labs stock appears to be undervalued.
The current stock price of HK$0.58 is trading 58% below its estimated GF Value™ of HK$1.38.
GuruFocus considers ETHK Labs to be Possible Value Trap.
Key valuation signals for HKSE:01931:
Market Cap: HK$929 Mil
GF Value™: HK$1.38 vs. price of HK$0.58 (58% below fair value)
No single metric tells the full story. See the HKSE:01931 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ETHK Labs Inc is engaged in the distribution, after-sales service, and development of in-vitro diagnostic (IVD) products in China. The company operates through three business segments: Distribution Business, After-sales Services, and Self-branded Products Business. It distributes IVD analysers, reagents, and consumables to hospitals and healthcare institutions, provides maintenance and installation services for diagnostic equipment, and develops and sells self-branded IVD analysers and reagents. The company generates the majority of its revenue from Mainland China.
74GF Score
Get the complete analysis for HKSE:01931
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01931 has been successfully added to your 
